{"groups":[{"description":"Patients receive administration of high dose cytosine arabinoside and mitoxantrone followed by hematopoietic cell transplant.","id":"FG000","title":"Cytarabine + Mitoxantrone"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"Only 1 patient was enrolled (yr 1999) and later died (yr 2000). Study was terminated due to low accrual."}